@article{510e25981b34410fb3803febac864f8a,
title = "Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma",
keywords = "Gene marking, Hodgkin's disease, Immunotherapy, Non-Hodgkin's lymphoma",
author = "Bollard, {Catherine M.} and Huls, {M. Helen} and Elizabeth Buza and Heidi Weiss and Vicky Torrano and Gresik, {Mary V.} and Jeff Chang and Adrian Gee and Gottschalk, {Stephen M.} and George Carrum and Brenner, {Malcolm K.} and Rooney, {Cliona M.} and Heslop, {Helen E.}",
note = "Funding Information: This study is supported by a Kimmel Translational Science Award and a Gillson Longenbaugh Foundation Award (CMB), National Institutes of Health grant PO1 CA94237, the GCRC at Baylor College of Medicine (RR00188), a Specialized Center of Research Award from the Leukemia Lymphoma Society, and a Doris Duke Distinguished Clinical Scientist Award (HEH).",
year = "2006",
month = jan,
doi = "10.3816/CLM.2006.n.011",
language = "English (US)",
volume = "6",
pages = "342--347",
journal = "Clinical Lymphoma and Myeloma",
issn = "1557-9190",
publisher = "Cancer Information Group, LP",
number = "4",
}